Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E French

Showing results (701-710 of 778) with videos related to

Pageof 78
Sort By:
Inflammatory Bowel Diseases|May 29, 2015
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease CohortStephan R Vavricka, Gerhard Rogler, Claudine Gantenbein, et al.
HGG Advances|May 19, 2022
Refinements and considerations for trio whole-genome sequence analysis when investigating Mendelian diseases presenting in early childhoodCourtney E French, Helen Dolling, Karyn Mégy, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2024
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitorsTheresa Ruf, Rafaela Kramer, Andrea Forschner, et al.
Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.
BMJ (Clinical Research Ed.)|April 15, 2026
Effectiveness of interventions to increase vaccine uptake: component network meta-analysisSarah R Davies, Annabel L Davies, Julian P T Higgins, et al.
Journal of the American Academy of Dermatology|September 13, 2021
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based studyDevon E McMahon, Carrie L Kovarik, William Damsky, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2023
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infectionsC Schmitt, E P Hoefsmit, T Fangmeier, et al.
JAMA Neurology|March 7, 2022
Multicenter Consensus Approach to Evaluation of Neonatal Hypotonia in the Genomic Era: A ReviewSarah U Morton, John Christodoulou, Gregory Costain, et al.
Neurology|December 19, 2024
Exome and Genome Sequencing to Diagnose the Genetic Basis of Neonatal Hypotonia: An International Consortium StudySarah U Morton, Gregory Costain, Courtney E French, et al.
The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.
Pageof 78

Showing results (701-710 of 778) with videos related to

Sort By:
Pageof 78
Inflammatory Bowel Diseases|May 29, 2015
Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease CohortStephan R Vavricka, Gerhard Rogler, Claudine Gantenbein, et al.
HGG Advances|May 19, 2022
Refinements and considerations for trio whole-genome sequence analysis when investigating Mendelian diseases presenting in early childhoodCourtney E French, Helen Dolling, Karyn Mégy, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2024
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitorsTheresa Ruf, Rafaela Kramer, Andrea Forschner, et al.
Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.
BMJ (Clinical Research Ed.)|April 15, 2026
Effectiveness of interventions to increase vaccine uptake: component network meta-analysisSarah R Davies, Annabel L Davies, Julian P T Higgins, et al.
Journal of the American Academy of Dermatology|September 13, 2021
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based studyDevon E McMahon, Carrie L Kovarik, William Damsky, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2023
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infectionsC Schmitt, E P Hoefsmit, T Fangmeier, et al.
JAMA Neurology|March 7, 2022
Multicenter Consensus Approach to Evaluation of Neonatal Hypotonia in the Genomic Era: A ReviewSarah U Morton, John Christodoulou, Gregory Costain, et al.
Neurology|December 19, 2024
Exome and Genome Sequencing to Diagnose the Genetic Basis of Neonatal Hypotonia: An International Consortium StudySarah U Morton, Gregory Costain, Courtney E French, et al.
The British Journal of Dermatology|January 23, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, et al.
Pageof 78